Stereotactic body radiotherapy in lung metastases from any non haematological primary cancer.

Stereotactic body radiotherapy (SBRT) is a new form of cancer radiotherapy treatment and there are two SABR techniques emerging in Australia; single session and multi session. This study will examine the safety of these two techniques used to treat metastatic disease to the lung, as determined by the various side effects, to determine which technique is the best to be used in Australia and New Zealand in the future

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

Australasian Lung Cancer Trials Group (ALTG)

Participating Centres

Final Accrual

90

Current Accrual

Trial Chairperson

A/Prof Shankar Siva, Peter MacCallum Cancer Centre, VIC

Trial Contact

SAFRONII@trog.com.au

Clinical Trial Registration

Related Post

February 28, 2022

Cancer trial participant hoping to help

The RAVES trial treating prostate cancer Participating in a

June 15, 2021

Individualising radiotherapy for women with DCIS of the breast reduces recurrence after surgery

Ductal carcinoma in situ (DCIS) of the breast is

Skip to toolbar